After his company, Colossal Biosciences, successfully revived the dire wolf from extinction, he's ready to continue to change ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...